Which symptom is most likely to improve with carbidopa-levodopa therapy in Parkinson disease?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the NMNC 4510 Concept Synthesis Test. Enhance your understanding with flashcards and multiple-choice questions, complete with hints and explanations. Get exam-ready today!

Multiple Choice

Which symptom is most likely to improve with carbidopa-levodopa therapy in Parkinson disease?

Explanation:
Parkinson disease motor symptoms arise from a dopamine deficit in the nigrostriatal pathways. Carbidopa-levodopa provides dopamine to the brain, with carbidopa blocking peripheral breakdown so more levodopa reaches the brain. This dopaminergic replacement especially helps resting tremor, a hallmark motor symptom driven by this deficit, so tremor is the symptom most likely to improve with therapy. Paresthesias are sensory, not primarily due to dopamine loss, and hyperglycemia or headaches are not typical motor symptoms of Parkinson’s that respond to dopaminergic treatment.

Parkinson disease motor symptoms arise from a dopamine deficit in the nigrostriatal pathways. Carbidopa-levodopa provides dopamine to the brain, with carbidopa blocking peripheral breakdown so more levodopa reaches the brain. This dopaminergic replacement especially helps resting tremor, a hallmark motor symptom driven by this deficit, so tremor is the symptom most likely to improve with therapy. Paresthesias are sensory, not primarily due to dopamine loss, and hyperglycemia or headaches are not typical motor symptoms of Parkinson’s that respond to dopaminergic treatment.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy